Novozymes Biopharma to launch new ophthalmic HA grade
Novozymes Biopharma will launch a new grade of its Bacillus-derived hyaluronic acid (HA) for ophthalmic delivery applications later this year.
Archives for May 18, 2011
CMO Gallus buys Centocor bio facility and plans investment
CMO Gallus BioPharmaceuticals has bought, and is investing in, a Centocor biologics facility after receiving private equity backing.